Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy

Despite modern treatment approaches, survival of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) remains low and it is difficult to identify patients who derive optimal benefit from treatment. We therefore analyzed which commonly available laboratory and cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnes, Teresa, Melchardt, Thomas, Weiss, Lukas, Mittermair, Christof, Neureiter, Daniel, Klieser, Eckhard, Gampenrieder, Simon, Moser, Gerhard, Gaggl, Alexander, Greil, Richard, Egle, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501656/
https://www.ncbi.nlm.nih.gov/pubmed/28686697
http://dx.doi.org/10.1371/journal.pone.0180995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501656/
https://www.ncbi.nlm.nih.gov/pubmed/28686697
http://dx.doi.org/10.1371/journal.pone.0180995

Ejemplares similares